Get the Stockscreener App
97.23
0.38%
-0.37
After Hours:
97.35
0.12
+0.12%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $97.23, with a volume of 5.40M.
It is down -0.38% in the last 24 hours and down -6.90% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$97.60
Open:
$97.82
24h Volume:
5.40M
Relative Volume:
0.68
Market Cap:
$124.35B
Revenue:
$407.94B
Net Income/Loss:
$2.90B
P/E Ratio:
42.70
EPS:
2.2771
Net Cash Flow:
$7.39B
1W Performance:
+3.09%
1M Performance:
-6.90%
6M Performance:
+19.07%
1Y Performance:
+31.23%
1-Day Range:
$96.90
$98.50
1-Week Range:
$92.85
$98.50
52-Week Range:
$69.51
$110.68
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
97.23 | 119.78B | 407.94B | 2.90B | 7.39B | 2.2771 |
UNH
Unitedhealth Group Inc
|
399.66 | 345.44B | 450.13B | 14.91B | 23.62B | 15.55 |
ELV
Elevance Health Inc
|
405.84 | 85.94B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
282.84 | 72.51B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
400.97 | 45.72B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-14-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
Resilient CVS Health stock holds in the low $90s as strong Q2 earnings and FY 2026 guidance support - Ad-hoc-news.de
Heart disease continues to disproportionately affect underserved communities | 2026-08-21 | Investing News - Stockhouse
CVS Health: Every Community Deserves a Healthier Heart - ACCESS Newswire
Mystic Asset Management Inc. Purchases New Stake in CVS Health Corporation $CVS - MarketBeat
48,550 Shares in CVS Health Corporation $CVS Acquired by Madison Asset Management LLC - MarketBeat
Vise Technologies Inc. Purchases New Position in CVS Health Corporation $CVS - MarketBeat
NewEdge Wealth LLC Purchases New Shares in CVS Health Corporation $CVS - MarketBeat
What Makes CVS Health (NYSE:CVS) a Focus After Dow Weakness? - Kalkine Media
B. Metzler seel. Sohn & Co. AG Buys Shares of 123,784 CVS Health Corporation $CVS - MarketBeat
9,013,571 Shares in CVS Health Corporation $CVS Purchased by Bank of New York Mellon Corp - MarketBeat
Advisors Capital Management LLC Acquires New Shares in CVS Health Corporation $CVS - MarketBeat
Temporary Mobile CVS Pharmacy Helps Restore Pharmacy Access in Pawling, NY, Following Fire - ACCESS Newswire
Westport Asset Management Inc. Makes New $1.84 Million Investment in CVS Health Corporation $CVS - MarketBeat
United Bank Invests $2.25 Million in CVS Health Corporation $CVS - MarketBeat
Tocqueville Asset Management L.P. Acquires Shares of 301,191 CVS Health Corporation $CVS - MarketBeat
Edmond DE Rothschild Holding S.A. Invests $29.86 Million in CVS Health Corporation $CVS - MarketBeat
17,720 Shares in CVS Health Corporation $CVS Acquired by Foster & Motley Inc. - MarketBeat
CVS Health Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
CVS Health stock holds steady as Argus lifts price target after strong Q2 earnings - Ad-hoc-news.de
ETFs Investing in CVS Health Corporation Stocks - TradingView
Can CVS Health (CVS) Stay Below Fair Value After Strong Results? - Yahoo Finance
How CVS Specialty helps patients overcome barriers to care - CVS Health
CVS Health and Aetna Help Florida City Families Prepare for the School Year at Branches' Back to School Night - ACCESS Newswire
CVS Health (NYSE:CVS) Given New $114.00 Price Target at Argus - MarketBeat
Argus Adjusts Price Target on CVS Health to $114 From $104, Keeps Buy Rating - marketscreener.com
Meeder Advisory Services Inc. Takes Position in CVS Health Corporation $CVS - MarketBeat
Great Lakes Advisors LLC Makes New Investment in CVS Health Corporation $CVS - MarketBeat
Diversify Advisory Services LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
Danske Bank A S Buys Shares of 890,499 CVS Health Corporation $CVS - MarketBeat
Aljian Capital Management LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
Is CVS Health (CVS) A Bargain On Raised Guidance And Board Changes? - Yahoo Finance
Why Is CVS Health (CVS) Adding A Data Leader To Its Board? - Yahoo Finance
CVS Health stock edges higher as strong Q2 earnings and 2026 guidance anchor valuation - AD HOC NEWS
F&V Capital Management, LLC's CVS Health Corp(CVS) Holding History - GuruFocus
CVS Health: Thank You! Enlightenment Plaza Voltaire Villas Volunteer Day in Los Angeles, California - Yahoo! Finance Canada
Every community deserves a healthier heart - CVS Health
How Should You Approach CVS Health Stock After Q2 Earnings? - The Globe and Mail
Costco Is Getting Into Medicare — Here’s What Its New Health Insurance Plans Could Mean for Seniors - Benzinga
Pzena Investment Management LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
Meeder Asset Management Inc. Invests $5.70 Million in CVS Health Corporation $CVS - MarketBeat
Perigon Wealth Management LLC Makes New Investment in CVS Health Corporation $CVS - MarketBeat
Pallas Capital Advisors LLC Makes New Investment in CVS Health Corporation $CVS - MarketBeat
Principle Wealth Partners LLC Purchases Shares of 20,714 CVS Health Corporation $CVS - MarketBeat
Trust Co. of Vermont Acquires New Stake in CVS Health Corporation $CVS - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in CVS Health Corporation $CVS - MarketBeat
CVS adds JPMorgan data executive to board amid AI push - Yahoo Finance
Focused Alpha LLC Makes New $1.34 Million Investment in CVS Health Corporation $CVS - MarketBeat
Commerzbank Aktiengesellschaft FI Buys Shares of 79,378 CVS Health Corporation $CVS - MarketBeat
Citizens Financial Group Inc. RI Takes Position in CVS Health Corporation $CVS - MarketBeat
Deutsche Bank AG Takes $466.63 Million Position in CVS Health Corporation $CVS - MarketBeat
BlackRock Inc. Buys Shares of 123,223,409 CVS Health Corporation $CVS - MarketBeat
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cvs Health Corp Stock (CVS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ROBBINS LARRY | Director |
May 19 '26 |
Sale |
94.45 |
1,983,538 |
187,341,308 |
6,213,261 |
| ROBBINS LARRY | Director |
May 20 '26 |
Sale |
93.82 |
1,018,000 |
95,510,822 |
5,195,261 |
| ROBBINS LARRY | Director |
May 21 '26 |
Sale |
93.45 |
370,462 |
34,619,007 |
4,824,799 |
0.69%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):